within Pharmacolibrary.Drugs.ATC.A;

model A03AB12
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.1,
    Cl             = 0.00011666666666666667,
    adminDuration  = 600,
    adminMass      = 25 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A03AB12</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Mepenzolate is an antimuscarinic/anticholinergic agent that has been used in the treatment of peptic ulcer disease and gastrointestinal disorders such as irritable bowel syndrome to reduce gastric acid secretion and intestinal motility. Its clinical use has decreased significantly and it is not commonly used or approved in most countries today.</p><h4>Pharmacokinetics</h4><p>No published, peer-reviewed human pharmacokinetic studies are available for mepenzolate. Pharmacokinetic parameters are estimated based on data for similar quaternary antimuscarinic agents.</p><h4>References</h4><ol><li><p>Tanaka, K, et al., &amp; Mizushima, T (2014). Superiority of pulmonary administration of mepenzolate bromide over other routes as treatment for chronic obstructive pulmonary disease. <i>Scientific reports</i> 4 4510–None. DOI:<a href=\"https://doi.org/10.1038/srep04510\">10.1038/srep04510</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24676126/\">https://pubmed.ncbi.nlm.nih.gov/24676126</a></p></li><li><p>Friedman, HL, &amp; Wang, RI (1972). Oral absorption of 14 C-labeled mepenzolate bromide in humans. <i>Journal of pharmaceutical sciences</i> 61(10) 1663–1665. DOI:<a href=\"https://doi.org/10.1002/jps.2600611033\">10.1002/jps.2600611033</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/5072426/\">https://pubmed.ncbi.nlm.nih.gov/5072426</a></p></li><li><p>Saitoh, H, et al., &amp; Arita, T (1986). Interaction of tertiary amines and quaternary ammonium compounds with gastrointestinal mucin. <i>Journal of pharmacobio-dynamics</i> 9(12) 1008–1014. DOI:<a href=\"https://doi.org/10.1248/bpb1978.9.1008\">10.1248/bpb1978.9.1008</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3572714/\">https://pubmed.ncbi.nlm.nih.gov/3572714</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A03AB12;
